BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12927520)

  • 21.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells.
    Cywes C; Godenir NL; Hoppe HC; Scholle RR; Steyn LM; Kirsch RE; Ehlers MR
    Infect Immun; 1996 Dec; 64(12):5373-83. PubMed ID: 8945590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
    Stokes RW; Thorson LM; Speert DP
    J Immunol; 1998 Jun; 160(11):5514-21. PubMed ID: 9605155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively.
    Le Cabec V; Carréno S; Moisand A; Bordier C; Maridonneau-Parini I
    J Immunol; 2002 Aug; 169(4):2003-9. PubMed ID: 12165526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes.
    Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z
    Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of pathogenic mycobacteria with host macrophages.
    Sundaramurthy V; Pieters J
    Microbes Infect; 2007; 9(14-15):1671-9. PubMed ID: 18023233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished adherence and/or ingestion of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients with tuberculosis.
    Zabaleta J; Arias M; Maya JR; García LF
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):690-4. PubMed ID: 9729537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages.
    Malik ZA; Denning GM; Kusner DJ
    J Exp Med; 2000 Jan; 191(2):287-302. PubMed ID: 10637273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis.
    Leemans JC; Florquin S; Heikens M; Pals ST; van der Neut R; Van Der Poll T
    J Clin Invest; 2003 Mar; 111(5):681-9. PubMed ID: 12618522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis.
    Hadas S; Reichert F; Rotshenker S
    Glia; 2010 May; 58(7):823-30. PubMed ID: 20091776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacteria, metals, and the macrophage.
    Neyrolles O; Wolschendorf F; Mitra A; Niederweis M
    Immunol Rev; 2015 Mar; 264(1):249-63. PubMed ID: 25703564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human macrophage host defense against Mycobacterium tuberculosis.
    Liu PT; Modlin RL
    Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyzing the interaction of pathogens with the host immune system.
    Jayachandran R; Scherr N; Pieters J
    Immunol Lett; 2009 Feb; 122(2):112-4. PubMed ID: 19135088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Entry and survival of pathogenic mycobacteria in macrophages.
    Pieters J
    Microbes Infect; 2001 Mar; 3(3):249-55. PubMed ID: 11358719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
    Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
    Front Immunol; 2018; 9():1123. PubMed ID: 29946317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages.
    Stokes RW; Doxsee D
    Cell Immunol; 1999 Oct; 197(1):1-9. PubMed ID: 10555990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis.
    BoseDasgupta S; Pieters J
    Semin Immunopathol; 2018 Nov; 40(6):577-591. PubMed ID: 30306257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology of tuberculosis.
    Raja A
    Indian J Med Res; 2004 Oct; 120(4):213-32. PubMed ID: 15520479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.
    Tailleux L; Schwartz O; Herrmann JL; Pivert E; Jackson M; Amara A; Legres L; Dreher D; Nicod LP; Gluckman JC; Lagrange PH; Gicquel B; Neyrolles O
    J Exp Med; 2003 Jan; 197(1):121-7. PubMed ID: 12515819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During
    Hoang KV; Rajaram MVS; Curry HM; Gavrilin MA; Wewers MD; Schlesinger LS
    Front Immunol; 2018; 9():561. PubMed ID: 29632532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.